Table 4.
Key conclusions from the toxicokinetics study of Völkel et al. (2002) in human subjects using deuterated BPA [d(16)-BPA]
| • 5 mg of d(16)-BPA (60–80 µg/kg/bw) were orally administered to human volunteers; blood and urine sampling was performed at predetermined time points. |
| • Maximum blood concentrations were measured approximately 80 minutes after administration. |
| • The half-life of d(16)-BPA was less than 6 hours. |
| • The administered doses were completely recovered in urine as d(16)-BPA-glucuronide. |
Note. Similar data were obtained by Doerge et al. (2010b), Kurebayashi et al. (2002), and Tominaga et al. (2006) in non-human primates.